Market Tracker

09/01 3:21am ET

Pernix Therapeutics Holdings Inc (NASDAQ:PTX)

8.69
Data as of Aug 29
 +0.26 / +3.08%
Today’s Change
1.68
Today|||52-Week Range
9.56
+244.84%
Year-to-Date

Today’s Trading

Previous close8.43
Today’s open8.42
Day’s range8.29 - 8.79
Volume234,341
Average volume (3 months)545,755
Market cap$330.6M
Dividend yield--
Data as of 3:59pm ET, 08/29/2014

Growth & Valuation

Earnings growth (last year)-1,300.00%
Earnings growth (this year)+20.71%
Earnings growth (next 5 years)+3.90%
Revenue growth (last year)+38.43%
P/E ratioNM
Price/Sales1.08
Price/Book2.92

Competitors

 Today’s
change
Today’s
% change
ZIOPZIOPHARM Oncology In...+0.08+2.54%
XNCRXencor Inc+0.40+3.89%
TGTXTG Therapeutics Inc-0.07-0.82%
TTPHTetraphase Pharmaceu...+0.21+1.63%
Data as of 3:59pm ET, 08/29/2014

Financials

Next reporting dateNovember 18, 2014
EPS forecast (this quarter)-$0.12
Annual revenue (last year)$84.9M
Annual profit (last year)-$25.6M
Net profit margin-30.20%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Other
Chairman, President &
Chief Executive Officer
Douglas L. Drysdale
Chief Operating Officer
Terence S. Novak
Corporate headquarters
Morristown, New Jersey

Forecasts